Why vaccine patents complicate responses to the Covid crisis
The collaboration necessary to create a vaccine at record speed could lead to legal battles over the parties involved in inventing the COVID vaccine. The outcome could yet again change the course of the pandemic.
UP NEXT
NOW PLAYING: other
Why vaccine patents complicate responses to the Covid crisis
CNBC
UP NEXT
-
Egypt has put in place economic tools to help deal with inflation, foreign minister says
CNBC
-
Amazon stands to gain 'wallet share' if consumer weakens, says Citi's Ronald Josey
-
Could falling stocks help curb spending?
-
Demand for office space jumps
-
Guggenheim Partners' Scott Minerd: We have not seen a dominant crypto player yet
-
The world has changed. Can Davos change along with it?
-
Interpol sec-gen: Only a matter of time before another cyberattack
-
Putin's actions are the reason Sweden is joining NATO, finance minister says
-
Will energy security derail the energy transition?
-
Intel CEO Pat Gelsinger: The U.S. needs more geographically balanced supply chains
-
U.S. is in an 'economic transition moment,' says senior Biden advisor
-
Alphabet CFO Ruth Porat on content moderation: We have to constructively engage with regulators
-
Can crypto clean up its dirty image?
-
Experts discuss how unlocking the social economy could help achieve sustainable development goals
-
Making vaccines is one thing, but we need to make sure they get into people's hands, AstraZeneca chairman says
-
Russian property investment in Dubai 'is a very small percentage,' DAMAC founder says
